AAAAAA
Results:
1-13
|
Results: 13
Authors:
Sculpher, M
Citation: M. Sculpher, Using economic evaluations to reduce the burden of asthma and chronic obstructive pulmonary disease, PHARMACOECO, 19, 2001, pp. 21-25
Authors:
Sculpher, M
Gafni, A
Citation: M. Sculpher et A. Gafni, Recognizing diversity in public preferences: The use of preference sub-groups in cost-effectiveness analysis, HEALTH ECON, 10(4), 2001, pp. 317-324
Authors:
Gilbert, RE
Augood, C
Gupta, R
Ades, AE
Logan, S
Sculpher, M
van der Meulen, JHP
Citation: Re. Gilbert et al., Screening for Down's syndrome: effects, safety, and cost effectiveness of first and second trimester strategies, BR MED J, 323(7310), 2001, pp. 423-425
Authors:
Sculpher, M
Drummond, M
O'Brien, B
Citation: M. Sculpher et al., Effectiveness, efficiency, and NICE - A NICE start but evidence costs money, BR MED J, 322(7292), 2001, pp. 943-944
Authors:
Sculpher, M
Thompson, E
Brown, J
Garry, R
Citation: M. Sculpher et al., A cost effectiveness analysis of goserelin compared with danazol as endometrial thinning agents, BR J OBST G, 107(3), 2000, pp. 340-346
Authors:
Akehurst, R
Anderson, P
Brazier, J
Brennan, A
Briggs, A
Buxton, M
Cairns, J
Calvert, N
Claxton, K
Dixon, S
Fryback, D
Gallivan, S
Green, C
Lloyd, A
McCabe, C
Mitchell, A
Nicholl, J
O'Brien, B
Roberts, J
Sculpher, M
Severens, H
Sullivan, S
Veenstra, D
Citation: R. Akehurst et al., Decision analytic modelling in the economic evaluation of health technologies - A consensus statement, PHARMACOECO, 17(5), 2000, pp. 443-444
Authors:
Sculpher, M
Fenwick, E
Claxton, K
Citation: M. Sculpher et al., Assessing quality in decision analytic cost-effectiveness models - A suggested framework and example of application, PHARMACOECO, 17(5), 2000, pp. 461-477
Authors:
Sculpher, M
Palmer, MK
Heyes, A
Citation: M. Sculpher et al., Costs incurred by patients undergoing advanced colorectal cancer therapy -A comparison of raltitrexed and fluorouracil plus folinic acid, PHARMACOECO, 17(4), 2000, pp. 361-370
Authors:
Sculpher, M
Citation: M. Sculpher, Evaluating the cost-effectiveness of interventions designed to increase the utilization of evidence-based guidelines, FAM PRACT, 17, 2000, pp. S26-S31
Authors:
Brown, J
Sculpher, M
Citation: J. Brown et M. Sculpher, Benefit valuation in economic evaluation of cancer therapies - A systematic review of the published literature, PHARMACOECO, 16(1), 1999, pp. 17-31
Authors:
Wellwood, J
Sculpher, M
Stoker, D
Citation: J. Wellwood et al., Laparoscopic versus open mesh repair of inguinal hernia, BR MED J, 318(7192), 1999, pp. 1214-1214
Authors:
Hoskins, G
Smith, B
Thomson, C
Sculpher, M
McCowan, C
Neville, R
Citation: G. Hoskins et al., The cost implications of an asthma attack, PED ASTHMA, 12(3), 1998, pp. 193-198
Authors:
Briggs, A
Sculpher, M
Britton, A
Murray, D
Fitzpatrick, R
Citation: A. Briggs et al., The costs and benefits of primary total hip replacement - How likely are new prostheses to be cost-effective?, INT J TE A, 14(4), 1998, pp. 743-761
Risultati:
1-13
|